ElizabethAlliElizabeth Alli PhD36.09032400000000-80.266491000000001839Alli, ElizabethBreast CancerOvarian CancerDrugs, AntineoplasticDrug DiscoveryChemopreventionTargeted Molecular TherapyExperimental TherapyChemotherapy Agents, CancerChemotherapies, CombinationTumorigenesisGenomic InstabilityCancer GenesBRCA1DNA RepairDNA Repair EnzymesBase Excision RepairDNA DamageOxidative DNA DamageOxidative StressGenetic PredispositionWomens HealthAssistant Professorprns:awardConferredByaward conferred byprns:endDateend dateFaculty Rankprns:fullNamefull nameprns:grantAwardedBygrant awarded byprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:physicalNeighborOfphysical neighborprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:principalInvestigatorNameprincipal investigator nameprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:startDatestart dateprns:trainingAtOrganizationeducational organizationprns:trainingLocationtraining locationprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressAgreementvivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipvivo:awardOrHonorawards and honorsAward or Honor Receiptvivo:degreeEarneddegree earnedDepartmentvivo:educationalTrainingeducation and trainingEducational Trainingvivo:freetextKeywordkeywordsGrantvivo:hasResearchArearesearch areasvivo:hasResearcherRoleresearch activitiesvivo:hrJobTitleHR job titleInformation Resourcevivo:linkAnchorTextlink anchor textvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:majorFieldmajor field of degreevivo:personInPositionpositionsPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titleResearcher Rolevivo:researcherRoleOfresearcher role ofRolevivo:roleContributesTocontributes tovivo:sponsorAwardIdsponsor award idURLLinkvivo:webpagewebpagerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD001943Disorders1566550.629374Breast NeoplasmsD004260Physiology31500.968588DNA RepairFeiXingFei Xing PhD36.09032400000000-80.266491000000001713Xing, FeiAssistant ProfessorKounosukeWatabeKounosuke Watabe PhD36.09032400000000-80.266491000000001727Watabe, KounosukeProfessorD050777Chemicals & Drugs130.996717StathminCancer BiologyWake Forest School of MedicineEdwardLevineEdward A. Levine MD36.08959100000000-80.26859900000000273Levine, EdwardProfessorAnthonyAtalaAnthony Atala MD36.08943500000000-80.268632000000003Atala, AnthonyProfessorNancyAvisNancy E. Avis PhD36.09550200000000-80.24393700000000709Avis, NancyProfessorWilliamGmeinerWilliam H. Gmeiner PhD36.09032400000000-80.2664910000000080Gmeiner, WilliamProfessorYusukeShiozawaYusuke Shiozawa MD, PhD36.09032400000000-80.266491000000001731Shiozawa, YusukeAssociate Professor1.863350.0054513492research areas21.58832.7940748similar to1114selected publicationsNeveenSaidNeveen Said MD, PhD36.09032400000000-80.266491000000001834Said, NeveenAssociate ProfessorAuthorship 476117Authorship 476161Authorship 476791Authorship 477181Authorship 477672Authorship 477891Authorship 478061Authorship 478875Authorship 479431Authorship 47977112006519Bash-Babula J, Toppmeyer D, Labassi M, Reidy J, Orlick M, Senzon R, Alli E, Kearney T, August D, Shih W, Yang JM, Hait WNClinical cancer research : an official journal of the American Association for Cancer ResearchBash-Babula J, Toppmeyer D, Labassi M, Reidy J, Orlick M, Senzon R, Alli E, Kearney T, August D, Shih W, Yang JM, Hait WN. A Phase I/pilot study of sequential doxorubicin/vinorelbine: effects on p53 and microtubule-associated protein 4. Clin Cancer Res. 2002 May; 8(5):1057-64.Clin Cancer Res2002-05-01T00:00:002002A Phase I/pilot study of sequential doxorubicin/vinorelbine: effects on p53 and microtubule-associated protein 4.12460900Alli E, Bash-Babula J, Yang JM, Hait WNCancer researchAlli E, Bash-Babula J, Yang JM, Hait WN. Effect of stathmin on the sensitivity to antimicrotubule drugs in human breast cancer. Cancer Res. 2002 Dec 01; 62(23):6864-9.Cancer Res2002-12-01T00:00:002002Effect of stathmin on the sensitivity to antimicrotubule drugs in human breast cancer.17272681Alli E, Yang JM, Ford JM, Hait WNMolecular pharmacologyAlli E, Yang JM, Ford JM, Hait WN. Reversal of stathmin-mediated resistance to paclitaxel and vinblastine in human breast carcinoma cells. Mol Pharmacol. 2007 May; 71(5):1233-40.Mol Pharmacol2007-02-01T00:00:002007Reversal of stathmin-mediated resistance to paclitaxel and vinblastine in human breast carcinoma cells.19351835Alli E, Sharma VB, Sunderesakumar P, Ford JMCancer researchAlli E, Sharma VB, Sunderesakumar P, Ford JM. Defective repair of oxidative dna damage in triple-negative breast cancer confers sensitivity to inhibition of poly(ADP-ribose) polymerase. Cancer Res. 2009 Apr 15; 69(8):3589-96.Cancer Res2009-04-07T00:00:002009Defective repair of oxidative dna damage in triple-negative breast cancer confers sensitivity to inhibition of poly(ADP-ribose) polymerase.20798217Hastak K, Alli E, Ford JMCancer researchHastak K, Alli E, Ford JM. Synergistic chemosensitivity of triple-negative breast cancer cell lines to poly(ADP-Ribose) polymerase inhibition, gemcitabine, and cisplatin. Cancer Res. 2010 Oct 15; 70(20):7970-80.Cancer Res2010-08-26T00:00:002010Synergistic chemosensitivity of triple-negative breast cancer cell lines to poly(ADP-Ribose) polymerase inhibition, gemcitabine, and cisplatin.21771338Alli E, Sharma VB, Hartman AR, Lin PS, McPherson L, Ford JMBMC pharmacologyAlli E, Sharma VB, Hartman AR, Lin PS, McPherson L, Ford JM. Enhanced sensitivity to cisplatin and gemcitabine in Brca1-deficient murine mammary epithelial cells. BMC Pharmacol. 2011 Jul 19; 11:7.BMC Pharmacol2011-07-19T00:00:002011Enhanced sensitivity to cisplatin and gemcitabine in Brca1-deficient murine mammary epithelial cells.22425348Alli E, Ford JMDNA repairAlli E, Ford JM. Breast cancers with compromised DNA repair exhibit selective sensitivity to elesclomol. DNA Repair (Amst). 2012 May 01; 11(5):522-4.DNA Repair (Amst)2012-03-14T00:00:002012Breast cancers with compromised DNA repair exhibit selective sensitivity to elesclomol.24166281Vinayak S, Schwartz EJ, Jensen K, Lipson J, Alli E, McPherson L, Fernandez AM, Sharma VB, Staton A, Mills MA, Schackmann EA, Telli ML, Kardashian A, Ford JM, Kurian AWBreast cancer research and treatmentVinayak S, Schwartz EJ, Jensen K, Lipson J, Alli E, McPherson L, Fernandez AM, Sharma VB, Staton A, Mills MA, Schackmann EA, Telli ML, Kardashian A, Ford JM, Kurian AW. A clinical trial of lovastatin for modification of biomarkers associated with breast cancer risk. Breast Cancer Res Treat. 2013 Nov; 142(2):389-98.Breast Cancer Res Treat2013-10-29T00:00:002013A clinical trial of lovastatin for modification of biomarkers associated with breast cancer risk.25217519Alli E, Solow-Cordero D, Casey SC, Ford JMCancer researchAlli E, Solow-Cordero D, Casey SC, Ford JM. Therapeutic targeting of BRCA1-mutated breast cancers with agents that activate DNA repair. Cancer Res. 2014 Nov 01; 74(21):6205-15.Cancer Res2014-09-12T00:00:002014Therapeutic targeting of BRCA1-mutated breast cancers with agents that activate DNA repair.25956865Alli E, Ford JMDNA repairAlli E, Ford JM. BRCA1: Beyond double-strand break repair. DNA Repair (Amst). 2015 Aug; 32:165-171.DNA Repair (Amst)2015-05-01T00:00:002015BRCA1: Beyond double-strand break repair.Authorship 49279127308455Alli E, Ford JMMolecular & cellular oncologyAlli E, Ford JM. BRCA1: a movement toward cancer prevention. Mol Cell Oncol. 2015 Jul-Sep; 2(3):e979685.Mol Cell Oncol2015-01-21T00:00:002015BRCA1: a movement toward cancer prevention.Authorship 609151Authorship 60916Hait WN, Rubin E, Alli E, Goodin S. Tubulin Update on Cancer TherapeuticsHait WN, Rubin E, Alli E, Goodin S. Tubulin . Tubulin Targeting Agents. Update on Cancer Therapeutics. 2007; 2(1):1-18.2007-01-01T00:00:002007Tubulin Targeting Agents16909102Alli E, Yang JM, Hait WNOncogeneAlli E, Yang JM, Hait WN. Silencing of stathmin induces tumor-suppressor function in breast cancer cell lines harboring mutant p53. Oncogene. 2007 Feb 15; 26(7):1003-12.Oncogene2006-08-14T00:00:002006Silencing of stathmin induces tumor-suppressor function in breast cancer cell lines harboring mutant p53.1995University of Southern CaliforniaLos Angeles, CAUniversity of Southern California, Exercise Science (major); Chemistry (minor)B.S.Exercise Science (major); Chemistry (minor)2001Rutgers University-Biomedical and Health SciencesNew Brunswick, NJRutgers University-Biomedical and Health Sciences, Molecular and Cellular PharmacologyM.S.Molecular and Cellular Pharmacology2006Rutgers University-Biomedical and Health SciencesNew Brunswick, NJRutgers University-Biomedical and Health Sciences, Molecular and Cellular PharmacologyPh.D.Molecular and Cellular Pharmacology2011Stanford University School of MedicineStanford, CAStanford University School of Medicine, Medicine-OncologyPostdocMedicine-OncologyUMDNJ-Department of Pharmacology20002000Young Investigator’s AwardState of New Jersey20012001Gallo Award for Cancer ResearchState of New Jersey20022002Award for Scientific ExcellenceAmerican Association for Cancer Research20052005Merck Scholar-in-Training AwardStanford University School of Medicine20072007Dean’s Postdoctoral FellowshipStanford University School of Medicine20072007Helena Anna Henzl Gabor Young Women in Science Travel AwardAmerican Association for Cancer Research20082008Bristol-Myers Squibb Oncology Scholar-in-Training AwardStanford University School of Medicine 20092009Helena Anna Henzl Gabor Young Women in Science Travel AwardStanford University School of Medicine20102010Helena Anna Henzl Gabor Young Women in Science Travel AwardAmerican Association for Cancer Research20142014Susan G. Komen Scholar-in-Training AwardStanford University School of Medicine20162015Spark Scholar AwardNIH/NCI20192015K22 Transition Career Development AwardSusan G. Komen Foundation20112008Postdoctoral Fellowship Award Wake Forest School of Medicine20172017Concept AwardErrett Fisher Foundation20182017Daryl and Marguerite Errett Discovery AwardPrincipal InvestigatorCo-InvestigatorCo-InvestigatorAuthorship 6205392023-02-28NIHKELLY, DEBORAH F2018-03-01Hot Spot Analysis of the Breast Cancer Susceptibility ProteinR01CA2272612023-05-31NIHKELLY, DEBORAH F2018-06-01Multi-scale imaging of breast cancer proteins during DNA repairR01CA2197002019-08-31NIHALLI, ELIZABETH2015-09-15Targeting defective DNA repair for the prevention of BRCA1-associated cancersK22CA18155030503669Liang Y, Dearnaley WJ, Alden NA, Solares MJ, Gilmore BL, Pridham KJ, Varano AC, Sheng Z, Alli E, Kelly DFDNA repairLiang Y, Dearnaley WJ, Alden NA, Solares MJ, Gilmore BL, Pridham KJ, Varano AC, Sheng Z, Alli E, Kelly DF. Correcting errors in the BRCA1 warning system. DNA Repair (Amst). 2019 01; 73:120-128.DNA Repair (Amst)2018-11-22T00:00:002018Correcting errors in the BRCA1 warning system.20Professor24Assistant Professor22Associate ProfessorSocial Sciences & Health Policy (Public Health Sciences)Surgery, OncologyUrologyhttp://www.wfirm.orgWFIRMtrue1Associate ProfessorAssociate Professortrue1ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1Assistant ProfessorAssistant Professortrue1Assistant ProfessorAssistant Professortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessorD019313Chemicals & Drugs6100.991755BRCA1 ProteinD004249Disorders47880.94478DNA Damage